Report cover image

U.S. Cannabis Market Growth, Size, Trends Analysis - By Source, By Derivative, By Cultivation, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Published Oct 09, 2025
Length 148 Pages
SKU # SPER20519999

Description

U.S. Cannabis Market Introduction and Overview

According to SPER market research, ‘U.S. Cannabis Market Size- By Source, By Derivative, By Cultivation, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the U.S. Cannabis Market is predicted to reach 119.79 billion by 2034 with a CAGR of 11.77%.

Cannabis, widely referred to as marijuana, weed, or pot, is a psychoactive substance derived from the cannabis plant. It possesses a long-standing history of utilization, serving both medical and recreational purposes. For centuries, it has been part of various cultural, religious, and spiritual practices. The drug can be consumed in multiple forms, including smoking dried flowers, using extracts like hashish, or incorporating it into food and beverages.

Restraints: The cannabis market also encounters considerable limitations due to stringent regulatory frameworks and varying legal statuses across different regions. Although some nations and states have sanctioned medical or recreational cannabis, numerous others continue to enforce strict prohibitions. Additionally, even in areas where cannabis is legalized, challenges such as taxation policies, intricate licensing requirements, and compliance costs confront market players.

Scope of the report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034

Segments covered
By Source, By Derivative, By Cultivation, By End-User

Regions covered
Northeast, Midwest, West, South

Companies Covered
Medical Marijuana, Inc, NuLeaf Naturals, LLC, CV Sciences, Inc, CHARLOTTE'S WEB, The Cronos Group, Organigram Holding, Inc, Irwin Naturals, Tilray Brands, Canopy Growth Corporation, Aurora Cannabis.

U.S. Cannabis Market Segmentation:

By Source: Based on the Source, U.S. Cannabis Market is segmented as; Hemp, Marijuana.

By Derivatives: Based on the Derivatives, U.S. Cannabis Market is segmented as; CBD, THC.

By Cultivation: Based on the Cultivation, U.S. Cannabis Market is segmented as; Indoor Cultivation, Greenhouse Cultivation, Outdoor Cultivation.

By End User: Based on the End User, U.S. Cannabis Market is segmented as; Industrial Use, Medical Use, Recreational Use.

By Region: This research also includes data for Northeast, Midwest, West, South.

Table of Contents

148 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. U. S. Cannabis Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U. S. Cannabis Market
7. U. S. Cannabis Market, By Source (USD Million) 2021-2034
7.1. Hemp
7.1.1. Hemp Oil
7.1.2. Industrial Hemp
7.2. Marijuana
7.2.1. Flower
7.2.2. Oil and Tinctures
8. U. S. Cannabis Market, By Derivatives (USD Million) 2021-2034
8.1. CBD
8.2. THC
8.3. Others
9. U. S. Cannabis Market, By Cultivation (USD Million) 2021-2034
9.1. Indoor Cultivation
9.2. Greenhouse Cultivation
9.3. Outdoor Cultivation
10. U. S. Cannabis Market, By End User (USD Million) 2021-2034
10.1. Industrial Use
10.2. Medical Use
10.2.1. Chronic Pain
10.2.2. Depression and Anxiety
10.2.3. Arthritis
10.2.4. Post-Traumatic Stress Disorder (PTSD)
10.2.5. Cancer
10.2.6. Migraines
10.2.7. Epilepsy
10.2.8. Alzheimer’s Disease
10.2.9. Multiple Sclerosis
10.2.10. AIDS
10.2.11. Amyotrophic Lateral Sclerosis
10.2.12. Tourette’s Syndrome
10.2.13. Diabetes
10.2.14. Parkinson's Disease
10.2.15. Glaucoma
10.2.16. Others
10.3. Recreational Use
11. U. S. Cannabis Market, (USD Million) 2021-2034
11.1. U. S. Cannabis Market Size and Market Share
12. U. S. Cannabis Market, By Region, (USD Million) 2021-2034
12.1. Northeast
12.2. Midwest
12.3. West
12.4. South
13. Company Profile
13.1. Medical Marijuana, Inc
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. NuLeaf Naturals, LLC
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. CV Sciences, Inc
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. CHARLOTTE’S WEB
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. The Cronos Group
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Organigram Holding, Inc
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Irwin Naturals
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Tilray Brands
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Canopy Growth Corporation
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Aurora Cannabis
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.